HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
At close: Dec 26, 2024
HTG Molecular Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Operating Revenue | 6.21 | 6.37 | 8.91 | 8.55 | 19.2 | 21.5 | Upgrade
|
| Revenue | 6.21 | 6.37 | 8.91 | 8.55 | 19.2 | 21.5 | Upgrade
|
| Revenue Growth (YoY) | -28.21% | -28.52% | 4.19% | -55.48% | -10.70% | 45.69% | Upgrade
|
| Cost of Revenue | 11.13 | 11.15 | 10.75 | 10.32 | 19.48 | 17.69 | Upgrade
|
| Gross Profit | -4.92 | -4.78 | -1.84 | -1.77 | -0.28 | 3.82 | Upgrade
|
| Selling, General & Admin | 14.46 | 15.84 | 17.35 | 18.29 | 18.68 | 19.97 | Upgrade
|
| Research & Development | 0.21 | 0.21 | 0.15 | - | - | - | Upgrade
|
| Operating Expenses | 14.67 | 16.05 | 17.5 | 18.29 | 18.68 | 19.97 | Upgrade
|
| Operating Income | -19.59 | -20.83 | -19.34 | -20.06 | -18.96 | -16.16 | Upgrade
|
| Interest Expense | -0.75 | -0.86 | -1.06 | -1.02 | -0.96 | -0.9 | Upgrade
|
| Interest & Investment Income | 0.19 | 0.09 | 0.03 | 0.25 | 0.62 | 0.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | - | 0.02 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -20.14 | -21.58 | -20.38 | -20.81 | -19.29 | -16.35 | Upgrade
|
| Asset Writedown | - | - | -0.18 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 3.44 | -0.05 | - | -0.11 | Upgrade
|
| Pretax Income | -20.14 | -21.58 | -17.12 | -20.86 | -19.29 | -16.45 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.02 | 0.01 | 0 | 0 | Upgrade
|
| Net Income | -20.15 | -21.59 | -17.15 | -20.87 | -19.3 | -16.45 | Upgrade
|
| Net Income to Common | -20.15 | -21.59 | -17.15 | -20.87 | -19.3 | -16.45 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 106.10% | 53.85% | 33.39% | 104.73% | 38.43% | 159.72% | Upgrade
|
| EPS (Basic) | -15.79 | -24.28 | -29.66 | -48.16 | -91.17 | -107.61 | Upgrade
|
| EPS (Diluted) | -15.79 | -24.28 | -29.66 | -48.16 | -91.17 | -107.61 | Upgrade
|
| Free Cash Flow | -16.85 | -18.43 | -17.15 | -16.75 | -17.8 | -14.12 | Upgrade
|
| Free Cash Flow Per Share | -13.21 | -20.73 | -29.68 | -38.64 | -84.09 | -92.37 | Upgrade
|
| Gross Margin | -79.14% | -75.07% | -20.70% | -20.67% | -1.45% | 17.74% | Upgrade
|
| Operating Margin | -315.21% | -327.19% | -217.18% | -234.64% | -98.73% | -75.15% | Upgrade
|
| Profit Margin | -324.28% | -339.20% | -192.49% | -244.13% | -100.49% | -76.52% | Upgrade
|
| Free Cash Flow Margin | -271.19% | -289.51% | -192.58% | -195.88% | -92.68% | -65.68% | Upgrade
|
| EBITDA | -19.1 | -20.24 | -18.62 | -18.71 | -17.7 | -14.69 | Upgrade
|
| EBITDA Margin | - | - | -209.08% | -218.89% | -92.17% | -68.32% | Upgrade
|
| D&A For EBITDA | 0.49 | 0.59 | 0.72 | 1.35 | 1.26 | 1.47 | Upgrade
|
| EBIT | -19.59 | -20.83 | -19.34 | -20.06 | -18.96 | -16.16 | Upgrade
|
| EBIT Margin | - | - | -217.18% | -234.64% | -98.73% | -75.15% | Upgrade
|
| Revenue as Reported | - | - | - | 8.55 | 19.2 | 21.5 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.